Clinical Trial Update: Naltrexone for Medication Compliance Among HIV-infected Men With Alcohol Use Disorder [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating naltrexone to improve medication compliance in HIV-infected men with alcohol use disorder; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Use Disorder
• HIV Infection

Drugs mentioned

• Naltrexone (Naltrexone)

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: HIV, Alcohol Use Disorder | Phase 4 | Status: COMPLETED